unknown
Stage
About
Forge Therapeutics develops first-in-class therapeutics targeting metalloprotein drug targets using a novel drug discovery platform focused on metalloenzyme chemistry.
Explore Forge Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.